ACRS FY 2024 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$435M

FY 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$19M-40.1% YoY

Gross Profit

$16M85.1% margin

Operating Income

-$142M-758.2% margin

Net Income

-$132M-705.5% margin

EPS (Diluted)

$-1.71

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$220M

Total Liabilities

$65M

Stockholders' Equity

$156M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$31M	-40.1%
Gross Profit	$16M	$13M	+21.0%
Operating Income	-$142M	-$97M	-45.8%
Net Income	-$132M	-$88M	-49.3%